Article

Negative pressure wound therapy reduces the effectiveness of traditional local antibiotic depot in a large complex musculoskeletal wound animal model.

Department of Regenerative Medicine, United States Army Institute of Surgical Research, Fort Sam Houston, TX, USA.
Journal of orthopaedic trauma (Impact Factor: 1.54). 04/2012; 26(9):512-8. DOI: 10.1097/BOT.0b013e318251291b
Source: PubMed

ABSTRACT Negative pressure wound therapy (NPWT) has been used to help manage open wounds. Surgeons also often use local antibiotic depot as adjunctive therapy in an effort to reduce infection rates. These 2 techniques have been reported to be used in conjunction, but there are little data to support this practice. We sought to compare the contamination levels of wounds treated with the commonly used antibiotic bead pouch technique to wounds that received both antibiotic beads and NWPT.
The effectiveness of a bead pouch was compared with antibiotic beads with NPWT. The anterior compartment and proximal tibia of goats were injured and inoculated with Staphylococcus aureus. Six hours later, the wounds were debrided and the animals were assigned to a group; the bacteria level was quantified immediately before and after initial debridement and 2 days after treatment.
The wounds in the antibiotic bead pouch group had 6-fold less bacteria than the augmented NPWT group, 11 ± 2% versus 67 ± 11% of baseline values, respectively (P = 0.01). As expected, high levels of the antibiotic were consistently recovered from the augmented NPWT effluent samples at all time points.
NPWT reduces the effectiveness of local antibiotic depot. These results can provide surgeons with the information to personalize the adjunctive therapies to individual patients, with the degree of difficulty in managing the wound and concern for infection being the 2 variables dictating treatment.

0 Followers
 · 
68 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Local delivery allows a high concentration of antibiotics to be achieved in the wound while avoiding the side effects and cost of systemic administration. Beads molded from polymethylmethacrylate (PMMA) cement are commonly used for local antibiotic delivery, but are not ideal. The purpose of this study was to determine if a bioabsorbable gel delivering vancomycin and gentamicin is more effective at reducing infection than beads delivering vancomycin and tobramycin. This study used a segmental defect rat model contaminated with Staphylococcus aureus and treated with clinically relevant local antibiotic doses, delivered by gel or beads. In the gel group, 1 ml of gel containing gentamicin and vancomycin was spread throughout the wound. In the bead group, four 3 mm beads containing tobramycin and vancomycin were placed in the wound, two in the defect and 2 in the adjacent tissue envelope, there was also a control group, which received no antibiotic treatment. After 14 days bone and hardware was harvested for separate microbiological analysis. There was a significantly lower infection rate in groups treated with antibiotics delivered by gel compared to those treated with either antibiotic beads or no antibiotics at all (p<0.001). Quantitative cultures also demonstrate significantly less bacteria in the wounds treated with the gel than in the control or bead groups (p≤0.004). These results suggest that antibiotic delivery by a gel is superior to beads. The authors propose that antibiotic depot by PMMA antibiotic beads is less effective because this method has to rely on diffusion of the antibiotic from the high concentration close to the beads to all regions of the wound.
    Journal of orthopaedic trauma 08/2013; DOI:10.1097/BOT.0b013e3182a7739e · 1.54 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The use of Negative Pressure Wound Therapy (NPWT) for complex and large wounds has increased in popularity over the past decade. Modern NPWT systems consisting of an open pore foam sponge, adhesive dressing and a vacuum pump producing negative pressure have been used as an adjunct to surgical debridement to treat tissue defects around open fractures and chronic, contaminated wounds. Other uses include supporting skin grafts and protecting wounds at risk of breaking down. This review outlines the current and emerging indications for negative pressure wound therapy in Orthopaedic trauma and the existing preclinical and clinical evidence base for its use.
    The Open Orthopaedics Journal 06/2014; 8(1):142-7. DOI:10.2174/1874325001408010142
  • [Show abstract] [Hide abstract]
    ABSTRACT: Prevention of extremity war wound infection remains a clinical challenge. Staphylococcus aureus is the most common pathogen in delayed infection. We hypothesised that choice of wound dressings may affect bacterial burden over 7 days reflecting the current practice of delayed primary closure of wounds within this timeframe. A randomised controlled trial of 3 commercially available dressings (Inadine® (Johnson & Johnson, New Jersey USA), Acticoat® (Smith & Nephew, Hull, UK), Activon Tulle (Advancis Medical, Nottingham, UK)) was conducted in a rabbit model of contaminated forelimb muscle injury. A positive control group treated with antibiotics was included. Groups were compared to a saline soaked gauze control. The primary outcome was a statistically significant reduction (p < 0.05) in tissue S aureus at 7 days post-injury. Secondary outcome measurements included bacteraemias, observational data, whole blood determination, ELISA for plasma biomarkers, PCR array analysis of wound healing gene expression and muscle/lymph node histopathology. Antibiotic, Inadine and Acticoat groups had statistically significant lower bacterial counts (mean 7.13 [95% CI 0.00-96.31] x 102; 1.66 [0.94-2.58] x 105; 8.86 [0.00-53.35] x 104 cfu/g respectively) and Activon Tulle group had significantly higher counts (2.82 [0.98-5.61] x 106 cfu/g) than saline soaked gauze control (7.58 [1.65-17.83] x 105 cfu/g). There were no bacteraemias or significant differences in observational data or whole blood determination. There were no significant differences in muscle/loss or pathology and lymph node cross-sectional area or morphology. There were some significant differences between treatment groups in the plasma cytokines IL-4, TNFα and MCP-1 in comparison to the control. PCR array data demonstrated more general changes in gene expression in the muscle tissue from the Activon Tulle group than the Inadine or Acticoat dressings with a limited number of genes showing significantly altered expression compared to control.
    Injury 08/2014; 45(8). DOI:10.1016/j.injury.2014.05.007 · 2.46 Impact Factor

Full-text

Download
0 Downloads
Available from
Mar 1, 2015